Souhaitez-vous accéder aux communiqués récents ?

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "China's Evolution in Global Drug Development and Clinical Trials" report has been added to ResearchAndMarkets.com's offering. This report examines...

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Aspects of Licensing Agreements Training Course (Dec 1st - Dec 2nd, 2025)" training has been added to ResearchAndMarkets.com's...

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "The Common Technical Document (CTD) Submission in the MENA Region Training Course (Nov 28, 2025)" training has been added to ResearchAndMarkets.com's...

Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "U.S. Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type of Synthesis (Biotech, Synthetic), by Type of...

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of...

Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea & Vomiting Induced by GLP-1 Receptor Agonist Semaglutide

The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards.

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "The Art of Technology Transfer in Drug Development: Developing and Building a Framework of Success (Aug 1, 2025)" training has been added to ...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "A Practical Guide to Producing and Maintaining the PSMF Training Course (Feb 13, 2026)" training has been added to ResearchAndMarkets.com's offering. ...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance (November 25, 2025)" training has been added to ResearchAndMarkets.com's...